VG
Schedule 13G filing
Viking Global Investors LP disclosed a 7% stake in CTY
Viking Global Investors LP reported owning 7% of City Therapeutics, Inc. (CTY) (3,727,005 shares) in a Schedule 13G filed Oct 26, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
More CTY insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.